Metronomic oral vinorelbine as first-line treatment in elderly patients with advanced non-small cell lung cancer: results of a phase II trial (MOVE trial)

被引：0
|
作者：
Andrea Camerini
Cheti Puccetti
Sara Donati
Chiara Valsuani
Maria Cristina Petrella
Gianna Tartarelli
Paolo Puccinelli
Domenico Amoroso
机构：
[1] Versilia Hospital and Istituto Toscano Tumori,Medical Oncology
来源：
BMC Cancer | / 15卷
关键词：
Elderly; Non-small-cell lung cancer; Metronomic vinorelbine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Metronomic oral vinorelbine as first-line treatment in elderly patients with advanced non-small cell lung cancer: results of a phase II trial (MOVE trial)
    Camerini, Andrea
    Puccetti, Cheti
    Donati, Sara
    Valsuani, Chiara
    Petrella, Maria Cristina
    Tartarelli, Gianna
    Puccinelli, Paolo
    Amoroso, Domenico
    BMC CANCER, 2015, 15
  • [2] PHASE II TRIAL OF METRONOMIC ORAL VINORELBINE AS FIRST-LINE TREATMENT IN ELDERLY PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER (MOVE TRIAL)
    Camerini, A.
    Puccetti, C.
    Donati, S.
    Valsuani, C.
    Petrella, M. C.
    Tartarelli, G.
    Puccinelli, P.
    Amoroso, D.
    ANNALS OF ONCOLOGY, 2014, 25
  • [3] Metronomic oral vinorelbine as first-line treatment in elderly patients with advanced non-small cell lung cancer: Preliminary results of a phase II trial (move trial)
    Camerini, A.
    Donati, S.
    Valsuani, C.
    Puccetti, C.
    Petrella, M. C.
    Tartarelli, G.
    Puccinelli, P.
    Amoroso, D.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S825 - S825
  • [4] Gemcitabine and vinorelbine as first-line chemotherapy for advanced non-small cell lung cancer:: a phase II trial
    Laack, E
    Mende, T
    Benk, J
    Chemaissani, A
    Scholtze, J
    Lorenz, C
    Niestroy, A
    Dalhoff, K
    Müller, T
    Walter, T
    Dürk, H
    Edler, L
    Hossfeld, DK
    EUROPEAN JOURNAL OF CANCER, 2001, 37 (05) : 583 - 590
  • [5] First-line Oral Vinorelbine for Elderly or Unfit Patients With Advanced/metastatic Non-small Cell Lung Cancer
    Mansueto, G.
    Longo, F.
    Stumbo, L.
    De Filippis, L.
    Del Signore, E.
    Quadrini, S.
    Del Bene, G.
    Adua, D.
    Lapadula, V.
    Di Seri, M.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S280 - S280
  • [6] Phase II trial of satraplatin and paclitaxel in the first-line treatment of advanced non-small cell lung cancer
    Shipley, D.
    Spigel, D. R.
    Cavanaugh, C.
    Moore, Y.
    Hainsworth, J. D.
    Jones, S.
    Burris, H. A., III
    Sade, L.
    Yardley, D. A.
    Greco, F.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [7] Docetaxel and gefitinib in the first-line treatment of elderly patients (≥ 70) with advanced non-small cell lung cancer (ANSCLC):: Results of phase II trial.
    Beple, G
    Williams, CC
    Chiappori, A
    Antonia, SJ
    Haura, EB
    Mahany, JJ
    Galloway, T
    Simon, GR
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 659S - 659S
  • [8] Prospective Phase II Trial of a Combination of Gemcitabine and UFT as First-line Treatment in Elderly Patients With Advanced Non-small Cell Lung Cancer
    Baek, J.
    Ahn, J.
    Jegal, Y.
    Park, C.
    Lee, Y.
    Cha, H.
    Kwon, W.
    Noh, Y.
    Park, J.
    Min, Y.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S621 - S621
  • [9] PROSPECTIVE PHASE II TRIAL OF A COMBINATION OF GEMCITABINE AND UFT AS FIRST-LINE TREATMENT IN ELDERLY PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER
    Baek, J. H.
    Kim, H.
    Kim, H. J.
    Park, J.
    Min, Y. J.
    ANNALS OF ONCOLOGY, 2010, 21 : 157 - 157
  • [10] Prospective phase II trial of a combination of gemcitabine and UFT as first-line treatment in elderly patients with advanced non-small cell lung cancer
    Baek, Jin Ho
    Kim, Hawk
    Ahn, Jong-Joon
    Jegal, Yangjin
    Seo, Kwang Won
    Ra, Seung Won
    Park, Chang Ryul
    Jung, Jong Pil
    Kim, Jeong Won
    Lee, Yong Jik
    Cha, Hee Jeong
    Kwon, Woon Jung
    Noh, Young Ju
    Oh, Sukjoong
    Park, Jae-Hoo
    Min, Young Joo
    LUNG CANCER, 2012, 76 (03) : 368 - 372
12345